Top 5 Large-cap gainers and losers this week!

List of top 5 gainers and losers this week in the Large-cap space.

Stock market bulls were blasted off by Vladimir Putin’s advance into Ukrainian territory that also tore down all defences on Dalal Street. Benchmark indices recorded their fourth-worst point-wise fall in history on Thursday. In the period from Friday i.e. February 18 to February 24, the blue-chip NSE Nifty 50 index declined 5.95% from 17,276 to 16,247. Similarly, the S&P BSE Sensex registered a decline of 5.71% from 57,382 to 54,529.

Among the sectoral indices, S&P BSE Consumer durables (-3.58%) and S&P Bse Fast Moving Consumer Goods (-5.31%) were the least impacted in the previous 5 trading sessions, whereas the S&P Bse Realty (-8.37%) and S&P BSE Oil & Gas (-8.31%) were among those most impacted.

Let us have a look at the top gainers and losers in the large-cap space during this period.

Abbott India:

Shares of Abbott India were buzzing on the bourses this week. The scrip rose 2.47% in the past 5 trading sessions, closing at Rs 16,777.60 on Thursday, and was among the top gainers among the Large Caps during this period. They have released Q3 results a few days back, where revenue was 11.5% up YoY, operating profit was 12% up YoY, while margins stayed flat with a 13% increase in net profit. In the last one-month share was trading volatile with anticipation of results and post result reaction.

Gland Pharma:

Shares of Gland Pharma were among the large caps stocks that rallied the most this week, rising 2.26% to close at Rs 3,296.15 on Thursday.  The previous week between 11 February and 18 February share was in the downtrend with a 9% down in that period. Gland Pharma has grown over the years from a contract manufacturer of small volume liquid parenteral products, to become one of the largest and fastest-growing injectable-focused companies, with a global footprint across 60 countries, including the United States, Europe, Canada, Australia, India and other markets.

Torrent Pharmaceuticals:

Torrent Pharmaceuticals was among the top performers among the large caps this week and was up by 0.44% in the last 5 trading sessions, closing at Rs 2,669 on Thursday.  Shares of Torrent Pharmaceuticals tanked about 15% in the last one month post the Q3 result announcement. It reported a weak set of numbers for the quarter. Revenue growth was at mid-single-digit and margins are in pressure along with bottom line degrowth of 16%. Torrent Pharmaceuticals Ltd is one of the leading Indian Pharmaceutical companies engaged in the research, development, manufacturing and marketing of generic pharmaceutical formulations.